LIWANLI Innovation Co., Ltd. (3054.TW)
TWD 23.5
(1.29%)
TWD 23.5
(1.29%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.06 TWD | 104.22% |
| 2022 | -1.50 TWD | -372.73% |
| 2021 | 0.55 TWD | 443.75% |
| 2020 | -0.16 TWD | -579.04% |
| 2019 | 0.03 TWD | 275.28% |
| 2018 | 0.01 TWD | -98.71% |
| 2017 | 0.69 TWD | -12.66% |
| 2016 | 0.79 TWD | 161.24% |
| 2015 | -1.29 TWD | -778.95% |
| 2014 | 0.19 TWD | -95.12% |
| 2013 | 3.89 TWD | 485.15% |
| 2012 | -1.01 TWD | -262.9% |
| 2011 | 0.62 TWD | -69.46% |
| 2010 | 2.03 TWD | 34.44% |
| 2009 | 1.51 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.29 TWD | -805.6% |
| 2024 Q2 | 0.04 TWD | 137.36% |
| 2024 Q1 | -0.11 TWD | -168.75% |
| 2023 Q3 | -0.18 TWD | -63.64% |
| 2023 Q2 | -0.11 TWD | -155.0% |
| 2023 Q1 | 0.20 TWD | 233.33% |
| 2023 FY | - TWD | 104.22% |
| 2023 Q4 | 0.16 TWD | 188.89% |
| 2022 Q2 | -0.97 TWD | -321.74% |
| 2022 FY | - TWD | -372.73% |
| 2022 Q4 | -0.15 TWD | 0.0% |
| 2022 Q1 | -0.23 TWD | -291.67% |
| 2022 Q3 | -0.15 TWD | 84.54% |
| 2021 FY | - TWD | 443.75% |
| 2021 Q1 | 0.14 TWD | 97.74% |
| 2021 Q2 | 1.32 TWD | 842.86% |
| 2021 Q3 | -1.04 TWD | -178.79% |
| 2021 Q4 | 0.12 TWD | 111.54% |
| 2020 Q2 | 0.21 TWD | 210.53% |
| 2020 Q1 | -0.19 TWD | -277.73% |
| 2020 FY | - TWD | -579.04% |
| 2020 Q4 | 0.07 TWD | 127.23% |
| 2020 Q3 | -0.26 TWD | -223.81% |
| 2019 FY | - TWD | 275.28% |
| 2019 Q2 | -0.17 TWD | -177.27% |
| 2019 Q3 | 0.04 TWD | 123.53% |
| 2019 Q1 | 0.22 TWD | 83.33% |
| 2019 Q4 | -0.05 TWD | -225.75% |
| 2018 Q3 | -0.22 TWD | -46.67% |
| 2018 Q2 | -0.15 TWD | -178.95% |
| 2018 Q4 | 0.12 TWD | 154.55% |
| 2018 FY | - TWD | -98.71% |
| 2018 Q1 | 0.19 TWD | -26.92% |
| 2017 Q4 | 0.26 TWD | 0.0% |
| 2017 Q1 | 0.51 TWD | 695.63% |
| 2017 Q2 | -0.19 TWD | -137.25% |
| 2017 Q3 | 0.26 TWD | 236.84% |
| 2017 FY | - TWD | -12.66% |
| 2016 Q4 | 0.06 TWD | -83.56% |
| 2016 Q1 | 0.28 TWD | 145.16% |
| 2016 FY | - TWD | 161.24% |
| 2016 Q2 | 0.07 TWD | -75.96% |
| 2016 Q3 | 0.39 TWD | 479.49% |
| 2015 Q1 | -0.22 TWD | -15.79% |
| 2015 FY | - TWD | -778.95% |
| 2015 Q4 | -0.62 TWD | -138.46% |
| 2015 Q3 | -0.26 TWD | -13.04% |
| 2015 Q2 | -0.23 TWD | -4.55% |
| 2014 Q4 | -0.19 TWD | -135.44% |
| 2014 FY | - TWD | -95.12% |
| 2014 Q1 | 0.36 TWD | 89.47% |
| 2014 Q2 | 0.08 TWD | -77.58% |
| 2014 Q3 | -0.08 TWD | -200.0% |
| 2013 Q4 | 0.19 TWD | -86.43% |
| 2013 FY | - TWD | 485.15% |
| 2013 Q1 | 1.33 TWD | 592.59% |
| 2013 Q2 | 1.04 TWD | -21.8% |
| 2013 Q3 | 1.40 TWD | 34.62% |
| 2012 Q3 | -0.81 TWD | -1303.57% |
| 2012 Q1 | 0.01 TWD | -96.52% |
| 2012 FY | - TWD | -262.9% |
| 2012 Q4 | -0.27 TWD | 66.67% |
| 2012 Q2 | 0.07 TWD | 566.34% |
| 2011 Q2 | -0.49 TWD | -228.95% |
| 2011 Q3 | 0.44 TWD | 189.8% |
| 2011 Q4 | 0.29 TWD | -34.09% |
| 2011 FY | - TWD | -69.46% |
| 2011 Q1 | 0.38 TWD | 741.89% |
| 2010 Q2 | -0.02 TWD | -107.0% |
| 2010 FY | - TWD | 34.44% |
| 2010 Q3 | 1.79 TWD | 8091.07% |
| 2010 Q1 | 0.32 TWD | 0.0% |
| 2010 Q4 | -0.06 TWD | -103.31% |
| 2009 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Grape King Bio Ltd | 9.81 TWD | 99.355% |
| Standard Chem & Pharm CO., LTD. | 4.67 TWD | 98.645% |
| Maywufa Company Ltd. | 1.27 TWD | 95.016% |
| ScinoPharm Taiwan, Ltd. | 0.36 TWD | 82.417% |
| Lotus Pharmaceutical Co., Ltd. | 15.72 TWD | 99.597% |
| YungShin Global Holding Corporation | 3.11 TWD | 97.965% |
| PhytoHealth Corporation | -0.24 TWD | 126.375% |
| SCI Pharmtech, Inc. | 2.70 TWD | 97.656% |
| Formosa Laboratories, Inc. | 1.05 TWD | 93.971% |
| PharmaEssentia Corporation | -1.93 TWD | 103.28% |
| Bora Pharmaceuticals Co., LTD. | 30.20 TWD | 99.79% |